vs
Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and Piedmont Realty Trust, Inc. (PDM). Click either name above to swap in a different company.
Piedmont Realty Trust, Inc. is the larger business by last-quarter revenue ($143.3M vs $104.5M, roughly 1.4× Immunocore Holdings plc). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs 0.4%). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs 0.0%).
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.
Piedmont Realty Trust, Inc. is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality office properties primarily located in high-growth metropolitan areas across the United States. It serves corporate tenants across multiple industry sectors including technology, professional services, and healthcare, and pursues stable long-term returns for stakeholders via strategic property management and portfolio optimization.
IMCR vs PDM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $104.5M | $143.3M |
| Net Profit | — | $-45.0M |
| Gross Margin | 97.4% | — |
| Operating Margin | -18.8% | — |
| Net Margin | — | -31.4% |
| Revenue YoY | 24.3% | 0.4% |
| Net Profit YoY | — | -27.9% |
| EPS (diluted) | $-0.61 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $143.3M | ||
| Q4 25 | $104.5M | $142.9M | ||
| Q3 25 | $103.7M | $139.2M | ||
| Q2 25 | $98.0M | $140.3M | ||
| Q1 25 | $93.9M | $142.7M | ||
| Q4 24 | $84.1M | $143.2M | ||
| Q3 24 | $80.2M | $139.3M | ||
| Q2 24 | $75.4M | $143.3M |
| Q1 26 | — | $-45.0M | ||
| Q4 25 | — | $-43.2M | ||
| Q3 25 | $-177.0K | $-13.5M | ||
| Q2 25 | $-10.3M | $-16.8M | ||
| Q1 25 | $5.0M | $-10.1M | ||
| Q4 24 | — | $-30.0M | ||
| Q3 24 | $8.7M | $-11.5M | ||
| Q2 24 | $-11.6M | $-9.8M |
| Q1 26 | — | — | ||
| Q4 25 | 97.4% | — | ||
| Q3 25 | 99.5% | — | ||
| Q2 25 | 98.9% | — | ||
| Q1 25 | 99.1% | — | ||
| Q4 24 | 99.6% | — | ||
| Q3 24 | 99.4% | — | ||
| Q2 24 | 97.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | -18.8% | — | ||
| Q3 25 | -6.9% | — | ||
| Q2 25 | -15.2% | — | ||
| Q1 25 | -3.9% | — | ||
| Q4 24 | -23.1% | — | ||
| Q3 24 | -10.6% | — | ||
| Q2 24 | -21.2% | — |
| Q1 26 | — | -31.4% | ||
| Q4 25 | — | -30.3% | ||
| Q3 25 | -0.2% | -9.7% | ||
| Q2 25 | -10.5% | -12.0% | ||
| Q1 25 | 5.4% | -7.1% | ||
| Q4 24 | — | -20.9% | ||
| Q3 24 | 10.9% | -8.3% | ||
| Q2 24 | -15.4% | -6.8% |
| Q1 26 | — | $-0.10 | ||
| Q4 25 | $-0.61 | $-0.34 | ||
| Q3 25 | $0.00 | $-0.11 | ||
| Q2 25 | $-0.20 | $-0.14 | ||
| Q1 25 | $0.10 | $-0.08 | ||
| Q4 24 | $-0.47 | $-0.25 | ||
| Q3 24 | $0.17 | $-0.09 | ||
| Q2 24 | $-0.23 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $864.2M | $2.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $381.0M | $1.5B |
| Total Assets | $1.1B | $4.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $2.3M | ||
| Q4 25 | $864.2M | $731.0K | ||
| Q3 25 | $892.4M | $3.0M | ||
| Q2 25 | $882.8M | $3.3M | ||
| Q1 25 | $837.0M | $2.9M | ||
| Q4 24 | $820.4M | $109.6M | ||
| Q3 24 | $901.3M | $133.6M | ||
| Q2 24 | $859.6M | $138.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.2B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $2.2B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | $438.7M | $2.2B | ||
| Q2 24 | $452.5M | $2.2B |
| Q1 26 | — | $1.5B | ||
| Q4 25 | $381.0M | $1.5B | ||
| Q3 25 | $396.6M | $1.5B | ||
| Q2 25 | $388.5M | $1.5B | ||
| Q1 25 | $378.5M | $1.6B | ||
| Q4 24 | $360.7M | $1.6B | ||
| Q3 24 | $377.8M | $1.6B | ||
| Q2 24 | $359.1M | $1.7B |
| Q1 26 | — | $4.0B | ||
| Q4 25 | $1.1B | $4.0B | ||
| Q3 25 | $1.1B | $4.0B | ||
| Q2 25 | $1.1B | $4.0B | ||
| Q1 25 | $1.0B | $4.0B | ||
| Q4 24 | $1.0B | $4.1B | ||
| Q3 24 | $1.1B | $4.1B | ||
| Q2 24 | $1.0B | $4.2B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.49× | ||
| Q3 25 | — | 1.43× | ||
| Q2 25 | — | 1.41× | ||
| Q1 25 | — | 1.40× | ||
| Q4 24 | — | 1.40× | ||
| Q3 24 | 1.16× | 1.36× | ||
| Q2 24 | 1.26× | 1.34× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-32.7M | — |
| Free Cash FlowOCF − Capex | $-35.5M | — |
| FCF MarginFCF / Revenue | -34.0% | — |
| Capex IntensityCapex / Revenue | 2.8% | 110.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-15.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-32.7M | $140.6M | ||
| Q3 25 | $-4.5M | $35.8M | ||
| Q2 25 | $26.0M | $50.1M | ||
| Q1 25 | $435.0K | $3.7M | ||
| Q4 24 | $-14.0M | $198.1M | ||
| Q3 24 | $21.1M | $42.9M | ||
| Q2 24 | $23.5M | $66.8M |
| Q1 26 | — | — | ||
| Q4 25 | $-35.5M | — | ||
| Q3 25 | $-5.2M | — | ||
| Q2 25 | $25.6M | — | ||
| Q1 25 | $137.0K | — | ||
| Q4 24 | $-17.5M | — | ||
| Q3 24 | $20.3M | — | ||
| Q2 24 | $23.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | -34.0% | — | ||
| Q3 25 | -5.0% | — | ||
| Q2 25 | 26.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | -20.9% | — | ||
| Q3 24 | 25.3% | — | ||
| Q2 24 | 30.7% | — |
| Q1 26 | — | 110.3% | ||
| Q4 25 | 2.8% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 4.3% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 0.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.42× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
